One study reported that TNFRSF12A promoted the invasive phenotype of IDH1 wild-type gliomas, while IDH1-mutant gliomas exhibited low TNFRSF12A mRNA and protein levels compared with IDH1 wild-type gliomas (47). The gene discussed is IDH1; the disease is central nervous system cancer.